BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

10x Genomics Expands Oncology Diagnostics Ambitions Through Cleveland Clinic Collaboration

Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platforms 10x...

June 19, 2026 | News

Dimerix Signs Up to AU$481 Million Licensing Deal with Everest Medicines to Advance Phase 3 Kidney Disease Therapy Across Asia

Dimerix Limited (ASX: DXB), a biopharmaceutical company developing innovative therapies for rare inflammatory diseases, has entered into an exclusive licen...

June 17, 2026 | News

QIAGEN Bets Big on Digital PCR with Major QIAcuity Ecosystem Expansion

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology applic...

June 16, 2026 | News

Everest Medicines Strengthens Asia Pacific Growth Strategy With Sumecigrel Licensing Agreement

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

June 10, 2026 | News

Ginkgo Datapoints, Tangible Scientific and Inductive Bio Launch ADME One to Accelerate Early Drug Discovery

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projec...

June 03, 2026 | News

Leica Biosystems, Indica Labs, And Lunit Advance AI Powered Digital Pathology For PD L1 Biomarker Analysis

Building on the market-defining computational pathology partnership between Leica Biosystems and Indica Labs, this new collaboration integrates Lunit's adv...

May 29, 2026 | News

Scribe Therapeutics Gains Australian Clearance To Begin First Human Trial Of STX 1150 For Hypercholesterolemia

Scribe Therapeutics, Inc. (Scribe), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to exte...

May 26, 2026 | News

Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...

May 26, 2026 | News

HistoSonics Secures Taiwan Approval For Edison Histotripsy System

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, announced it has received approval from the Taiwan...

May 21, 2026 | News

BIOTRONIK, Charité – Universitätsmedizin Berlin And German Heart Center Foundation Launch Digital Cardiology Innovation Alliance

Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology BIOTRONIK, die Charité – Universitätsmedizin Berlin, and t...

May 20, 2026 | News

Elabscience Bionovation Inc. Launches PolyHRP Streptavidin Conjugate To Enhance High Sensitivity ELISA Detection

Elabscience® Bionovation Inc. ("Elabscience®" or "the Company") announced the launch of its self-developed PolyHRP-Streptavidin conjugat...

May 18, 2026 | News

Australia’s NinaMED Launches With $13.75 Million Financing To Advance Global Commercialisation Of Non Invasive OAB Therapy

US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd, a new Australian medtech com...

May 15, 2026 | News

FDA Approves First All Oral INQOVI Plus Venetoclax Regimen For Newly Diagnosed AML Patients Ineligible For Intensive Chemotherapy

Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has approved INQOVI (decitabine and ced...

May 15, 2026 | News

Sichuan Kelun-Biotech Biopharmaceutical Secures China IND Clearance For PD 1 x VEGF Bispecific SKB118 In Advanced Solid Tumours

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical trial notice from t...

May 14, 2026 | News

Stay Connected